Business Daily from THE HINDU group of publications
Saturday, Apr 05, 2008
ePaper | Mobile/PDA Version


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Money & Banking - Credit Market
Industry & Economy - Pharmaceuticals
Get Latest BSE Quote
SBI loan product for pharma SMEs

To meet mandatory green norms

G. Naga Sridhar

Hyderabad, April 4 The Small and Medium Enterprises (SMEs) in pharmaceuticals industry can now look forward to financial assistance to meet the mandatory environmental norms, thanks to an exclusive term loan product being offered by the State Bank of India (SBI).

All the bulk drug manufacturers should ensure compliance to ‘Schedule M’ (for clearance from environmental authorities).

This is also important for other certifications from US Food and Drug Administration (US FDA) and Good Manufacturing Practices (GMP) required for exports.

Andhra pilot

“We have just launched the product on a pilot basis in Andhra Pradesh in view of the large number of pharma companies here. The extension of the product to other places will be examined later,” Mr Simon Fernandez, Deputy General Manager (SMEs), State Bank of India told Business Line here.

The term loan would also help SME drug manufacturers to fulfil the eco norms for up gradation of their capacities, and it is the first time that a major bank has launched an exclusive loan for meeting these requirements.

It increases the repayment period by two years i.e. longer repayment period with moratorium of 2 years as it takes normally 18-24 months to get the quality certification and comes with a lower margin (10) per cent from the clients, he added.

German collaboration

The design and launch of the product was done by SBI in collaboration with the German Technical Corporation (GTZ).

“This is a very crucial offer for the bulk drug industry. The cost of schedule M/Gmp compliance varies among units based on their current level of infrastructure and is estimated to vary between Rs 40 lakh to Rs 1.5 crore.

“Similar is the case with upgradation of pollution control equipment. Most of the units need to upgrade their PCEs to meet the current standards,” Mr N. Gurumurthy, Project Manager (Financial Services), GTZ said.

More Stories on : Credit Market | Pharmaceuticals | SSI | State Bank of India | Environment

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Rupee closes higher


Promoters of insurance cos can do brokerage too: IRDA
Shriram City Union Fin to raise Rs 400 cr thru pref allotment
Bond prices down 60 paise
SBI loan product for pharma SMEs
Call rates lower
Balance growth and inflation, says Kamath
Bankers readying for wider repo rates band


BusinessLine E-paper



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line